SCHEMBL2775693

SCHEMBL2775693

CCN(N)c1ccc(OC)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 5/20 0.52
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
CA14 Q9ULX7 1/20 0.48
TDP1 Q9NUW8 2/20 0.44
MAPK1 P28482 2/20 0.44
ALDH1A1 P00352 2/20 0.43
CYP3A4 P08684 1/20 0.43
SLC2A1 P11166 1/20 0.42
IDO1 P14902 3/20 0.42
AGXT P21549 2/20 0.42
NR1I2 O75469 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
GFER P55789 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6531270 0.79 AOC3 (0.45) AOC3CA12CA1CA2CA7
SCHEMBL1263095 0.77 ALDH1A1 (0.60) AOC3CA12CA1CA2CA7
SCHEMBL24247974 0.77 CA1 (0.52) AOC3CA12CA1CA2CA7
SCHEMBL17461082 0.77 CA1 (0.58) AOC3CA12CA1CA2CA7
SCHEMBL1573622 0.76 CA1 (0.65) CA12CA1CA2CA7CA9
SCHEMBL6233100 0.76 CA1 (0.65) CA12CA1CA2CA7CA9
SCHEMBL4745147 0.76 CA1 (0.50) AOC3CA12CA1CA2CA7
SCHEMBL11852811 0.75 KEAP1 (0.45) AOC3CA1CA2ALDH1A1MAPT
SCHEMBL9779992 0.75 KEAP1 (0.56) CA1CA2
SCHEMBL1871474 0.75 LTA4H (0.53) AOC3TDP1MAPK1ALDH1A1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010091543-A1 NOVEL HYDRAZINO-CYCLOBUT-3-ENE-1, 2-DIONE DERIVATIVES AS CXCR2 ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2010-08-19 WO disclosed
WO-2010091543-A1 NOVEL HYDRAZINO-CYCLOBUT-3-ENE-1, 2-DIONE DERIVATIVES AS CXCR2 ANTAGONISTS MERCK SHARP & DOHME CORP. (US) 2010-08-19 WO disclosed